Effects of Nifedipine on Bryostatin 1 Muscle Toxicity
Author Information
Author(s): CH Thompson, VM Macaulay, KJ O'Byrne, GJ Kemp, SM Wilner, DC Talbot, AL Harris, GK Radda
Primary Institution: MRC Biochemical and Clinical Magnetic Resonance Unit, Oxford Radcliffe Hospital, Oxford, UK
Hypothesis
Does nifedipine mitigate the muscle toxicity caused by bryostatin 1?
Conclusion
Nifedipine did not reduce the clinical toxicity of bryostatin 1, which is likely not due to vasoconstriction.
Supporting Evidence
- Nifedipine impaired muscle oxidative metabolism but did not affect proton efflux or muscle reoxygenation rate.
- Two effects of bryostatin were abolished in the presence of nifedipine, but impaired mitochondrial activity remained.
- Nifedipine did not allow a greater number of bryostatin courses to be administered.
Takeaway
This study looked at whether a medicine called nifedipine could help reduce muscle pain caused by another medicine called bryostatin. It found that nifedipine didn't help with the pain.
Methodology
The study used 31P magnetic resonance spectroscopy and near infrared spectroscopy to assess muscle metabolism and reoxygenation in patients with melanoma receiving bryostatin and nifedipine.
Limitations
The study had a small sample size and did not assess the effects of nifedipine on mitochondrial function in detail.
Participant Demographics
Six physically active patients with malignant melanoma.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website